Home

cap trial

May 15, 2020: Optimized Learning While Doing: The REMAP-CAP Adaptive  Platform Trial (Derek Angus, MD, MPH) - Rethinking Clinical Trials
May 15, 2020: Optimized Learning While Doing: The REMAP-CAP Adaptive Platform Trial (Derek Angus, MD, MPH) - Rethinking Clinical Trials

Camrelizumab plus apatinib in patients with high-risk chemorefractory or  relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm,  open-label, phase 2 trial - The Lancet Oncology
Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial - The Lancet Oncology

COVID study wins Trial of the Year award - Medicine, Nursing and Health  Sciences
COVID study wins Trial of the Year award - Medicine, Nursing and Health Sciences

Seven- to eight-year follow-up of the CoolCap trial of head cooling for  neonatal encephalopathy | Pediatric Research
Seven- to eight-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy | Pediatric Research

Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch  adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised,  non-inferiority, antimicrobial stewardship intervention trial - The Lancet  Infectious Diseases
Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial - The Lancet Infectious Diseases

Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community  Acquired Pneumonia (ATTACC-CAP ) | Trial or Study
Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP ) | Trial or Study

REMAP-CAP and Why we need Platform Trials in a Pandemic - YouTube
REMAP-CAP and Why we need Platform Trials in a Pandemic - YouTube

REMAP-CAP - Combacte
REMAP-CAP - Combacte

REMAP-CAP – The Bottom Line
REMAP-CAP – The Bottom Line

The CAP-IT Trial: Amoxicillin Dose and Duration in Children with  Community-Acquired Pneumonia - REBEL EM - Emergency Medicine Blog
The CAP-IT Trial: Amoxicillin Dose and Duration in Children with Community-Acquired Pneumonia - REBEL EM - Emergency Medicine Blog

Randomized, Embedded, Multifactorial Adaptive Platform trial for  Community-Acquired Pneumonia (REMAP-CAP- COVID) - Sunnybrook Research  Institute
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP- COVID) - Sunnybrook Research Institute

Accelerating Clinical Evaluation of Repurposed Combination Therapies for  COVID-19 in: The American Journal of Tropical Medicine and Hygiene Volume  103 Issue 4 (2020)
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19 in: The American Journal of Tropical Medicine and Hygiene Volume 103 Issue 4 (2020)

Grand Rounds August 11, 2023: The REMAP-CAP Adaptive Platform Trial: Recent  Insights and Future Directions (Patrick Lawler, MD, MPH) - Rethinking  Clinical Trials
Grand Rounds August 11, 2023: The REMAP-CAP Adaptive Platform Trial: Recent Insights and Future Directions (Patrick Lawler, MD, MPH) - Rethinking Clinical Trials

Media — REMAP-CAP Trial
Media — REMAP-CAP Trial

DVIDS - Images - Crew chief safety "bump cap" trial [Image 2 of 8]
DVIDS - Images - Crew chief safety "bump cap" trial [Image 2 of 8]

ProtecT and CAP trial recruitment phases and endpoint assessment... |  Download Scientific Diagram
ProtecT and CAP trial recruitment phases and endpoint assessment... | Download Scientific Diagram

Momentum 3 Trial - CAP Publication | Abbott
Momentum 3 Trial - CAP Publication | Abbott

REMAP-CAP
REMAP-CAP

REMAP-CAP • Coronavirus
REMAP-CAP • Coronavirus

Capricor Therapeutics Announces Continuation of Phase 3 HOPE-3 Trial -  CureDuchenne
Capricor Therapeutics Announces Continuation of Phase 3 HOPE-3 Trial - CureDuchenne

Understanding Adaptive Platform Trials & REMAP-CAP - SingHealth
Understanding Adaptive Platform Trials & REMAP-CAP - SingHealth

March: Prostate cap trial | News and features | University of Bristol
March: Prostate cap trial | News and features | University of Bristol

CAP trial design. *Further n = 1451 excluded due to prostate cancer... |  Download Scientific Diagram
CAP trial design. *Further n = 1451 excluded due to prostate cancer... | Download Scientific Diagram

HOPE-3 trial of DMD therapy CAP-1002 to continue as planned
HOPE-3 trial of DMD therapy CAP-1002 to continue as planned

ASCOT and REMAP-CAP awarded nearly $4 million to combine platforms to –  ASCOT: The Australasian COVID-19 Trial
ASCOT and REMAP-CAP awarded nearly $4 million to combine platforms to – ASCOT: The Australasian COVID-19 Trial

Celebrating REMAP – CAPs success on International Clinical Trials Day –  ACTA – Australian Clinical Trials Alliance
Celebrating REMAP – CAPs success on International Clinical Trials Day – ACTA – Australian Clinical Trials Alliance